Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

FDA grants priority review and breakthrough status to GSK's Hepatitis B "functional cure"

GSK (NYSE:GSK) and partner Ionis Pharmaceuticals (NASDAQ:IONS) announced on Tuesday, April 28, 2026, that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for bepirovirsen and granted it Priority Review.

Leia mais: FDA grants priority review and breakthrough status to GSK's Hepatitis B "functional cure"